An HLA-DR1 transgene confers susceptibility to collagen-induced arthritis elicited with human type II collagen

Journal of Experimental Medicine

Volumn 185, Issue 6, 1997, Pages 1113-1122

  Rosloniec, Edward F ^c,d   Brand, David D ^c,d   Myers, Linda K ^c   Whittington, Karen B ^d   Gumanovskaya, Marina ^c   Zaller, Dennis M ^a   Woods, Andrea ^a   Altmann, Daniel M ^b   Stuart, John M ^c,d   Kang, Andrew H ^c,d  

^a MERCK RESEARCH LABORATORIES   (United States)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; EPITOPE; HLA DR3 ANTIGEN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; AUTOIMMUNITY; CHIMERA; CROSS REACTION; HLA SYSTEM; HYPOTHESIS; IMMUNIZATION; IMMUNOFLUORESCENCE; IMMUNOTHERAPY; INFLAMMATION; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; SEQUENTIAL ANALYSIS; TRANSGENE;

ADJUVANTS, IMMUNOLOGIC; AMINO ACID SEQUENCE; ANIMALS; ANTIBODY FORMATION; ARTHRITIS, EXPERIMENTAL; B-LYMPHOCYTES; BASE SEQUENCE; COLLAGEN; DISEASE SUSCEPTIBILITY; DNA PRIMERS; EXONS; HLA-DR1 ANTIGEN; HUMANS; IMMUNITY, CELLULAR; JOINTS; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; POLYMERASE CHAIN REACTION; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES;

EID: 0030903740     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.185.6.1113     Document Type: Article

References (44)

1. Stastny, P., E.J. Ball, P.J. Dry, and G. Nunez. 1983. The human immune response region (HLA-D) and disease susceptibility. Immunol. Rev. 70:113-154.
2. Stastny, P., E. Ball, M. Kahn, N. Olsen, T. Pincus, and X. Gao. 1988. HLA-DR4 and other genetic markers in rheumatoid arthritis. Br. J. Rheumatol. 27:132-138.
3. Nepom, G.T., P. Byers, C. Seyfried, L.A. Healey, K.R. Wilske, D. Stage, and B.S. Nepom. 1989. HLA genes associated with rheumatoid arthritis. Identification of susceptibility alleles using specific oligonucleotide probes. Arthritis Rheum. 32: 15-21.
4. Wordsworth, B.P., J.S. Lanchbury, L.I. Sakkas, K.I. Welsh, G.S. Panayi, and J.I. Bell. 1989. HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class II region. Proc. Natl. Acad. Sci. USA. 86:10049-10053.
5. Gregersen, P., J. Silver, and R. Winchester. 1987. The shared epitope hypothesis: an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 30:1205-1213.
6. Winchester, R., E. Dwyer, and S. Rose. 1992. The genetic basis of rheumatoid arthritis. The shared epitope hypothesis. Rheum. Dis. Clin. N. Am. 18:761-783.
7. Zanelli, E., M.A. Gonzalez-Gay, and C.S. David. 1995. Could HLA-DRB1 be the protective locus in rheumatoid arthritis? Immunol. Today. 16:274-278.
8. Penzotti, J.E., D. Doherty, T.P. Lybrand, and G.T. Nepom. 1996. A structural model for TCR recognition of the HLA class II shared epitope sequence implicated in susceptibility to rheumatoid arthritis. J. Autoimmun. 9:287-293.
9. Roudier, J., G. Rhodes, J. Petersen, J.H. Vaughan, and D.A. Carson. 1988. The Epstein-Barr virus glycoprotein gp 110, a molecular link between HLA DR4, HLA DR1, and rheumatoid arthritis. Scand. J. Immunol. 27:367-371.
10. Fujinami, R.S., J.A. Nelson, L. Walker, and M.B. Oldstone. 1988. Sequence homology and immunologic cross-reactivity of human cytomegalovirus with HLA-DR beta chain: a means for graft rejection and immunosuppression. J. Virol. 62:100-105.
11. Yoo, T.J., S.Y. Kim, J.M. Stuart, R.A. Floyd, G.A. Olson, M.A. Cremer, and A.H. Kang. 1988. Induction of arthritis in monkeys by immunization with type II collagen. J. Exp. Med. 168:777-782.
12. Courtenay, J.S., M.J. Dallman, A.D. Dayan, A. Martin, and B. Mosedale. 1980. Immunisation against heterologous type II collagen induces arthritis in mice. Nature (Lond.). 283: 666-668.
13. Trentham, D.E., A.S. Townes, and A.H. Kang. 1977. Autoimmunity to type II collagen: an experimental model of arthritis. J. Exp. Med. 146:857-868.
14. Banerjee, S., H.S. Luthra, S.B. Moore, and W.M. O'Fallon. 1988. Serum IgG anti-native type II collagen antibodies in rheumatoid arthritis: association with HLA DR4 and lack of clinical correlation. Clin. Exp. Rheumatol. 6:373-380.
15. Londei, M., C.M. Savill, A. Verhoef, F. Brennan, Z.A. Leech, V. Duance, R.N. Maini, and M. Feldman. 1989. Persistence of collagen type II-specific T-cell clones in the synovial membrane of a patient with rheumatoid arthritis. Proc. Natl. Acad. Sci. USA. 86:636-640.
16. 125I-radioimmunoassay. Arthritis Rheum. 26:832-840.
17. Watson, W.C., R.E. Tooms, P.G. Carnesale, and J.P. Dutkowsky. 1994. A case of germinal center formation by CD45RO T and CD20 B lymphocytes in rheumatoid arthritic subchondral bone: proposal for a two-compartment model of immune-mediated disease with implications for immunotherapeutic strategies. Clin. Immunol. Immunopathol. 73: 27-37.
18. Woods, A., H.Y. Chen, M.E. Trumbauer, A. Sirotina, R. Cummings, and D.M. Zaller. 1994. Human major histocompatibility complex class II-restricted T cell responses in transgenic mice. J. Exp. Med. 180:173-181.
19. Miller, E.J. 1971. Isolation and characterization of the cyanogen bromide peptides from the α1(II) chain of chick cartilage collagen. Biochemistry. 10:3030-3035.
20. Stuart, J.M., M.A. Cremer, A.S. Townes, and A.H. Kang. 1982. Type II collagen induced arthritis in rats. Passive transfer with serum and evidence that IgG anticollagen antibodies can cause arthritis. J. Exp. Med. 155:1-16.
21. Wooley, P.H., H.S. Luthra, J.M. Stuart, and C.S. David. 1981. Type II collagen induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J. Exp. Med. 154:688-700.
22. Maeji, N.J., A.M. Bray, and H.M. Geysen. 1990. Multi-rod peptide synthesis strategy for T cell determinant analysis. J. Immunol. Methods. 134:23-33.
23. q mice. J. Immunol. 152: 3088-3097.
24. Click, R.E., L. Benck, and B.J. Alter. 1972. Immune response in vitro. I. Culture conditions for antibody synthesis. Cell. Immunol. 3:264-270.
25. Marrack, P. 1982. Production of antigen-specific H-2 restricted T cell hybridomas. In Isolation, Characterization, and Utilization of T Lymphocyte Clones. C.G. Fathman and F. Fitch, editors. Academic Press, New York. 119-126.
26. White, J., M. Blackman, J. Bill, J. Kappler, P. Marrack, D.P. Gold, and W. Born. 1989. Two better cell lines for making hybridomas expressing specific T cell receptors. J. Immunol. 143:1822-1825.
27. Klohe, E.P., R. Watts, M. Bahl, C. Alber, W.Y. Yu, R. Anderson, J. Silver, P.K. Gregersen, and R.W. Karr. 1988. Analysis of the molecular specificities of anti-class II monoclonal antibodies by using L cell transfectants expressing HLA class II molecules. J. Immunol. 141:2158-2164.
28. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65:55-63.
29. Denizot, F., and L. Rita. 1986. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Methods. 89:271-277.
30. Kappler, J.W., B. Skidmore, J. White, and P. Marrack. 1981. Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition. J. Exp. Med. 153:1198-1214.
31. Myers, L.K., J.M. Stuart, and A.H. Kang. 1989. A CD4 cell is capable of transferring suppression of collagen-induced arthritis. J. Immunol. 143:3976-3980.
32. Altmann, D.M., D.C. Douek, A.J. Frater, C.M. Hetherington, H. Inoko, and J.I. Elliott. 1995. The T cell response of HLA-DR transgenic mice to human myelin basic protein and other antigens in the presence and absence of human CD4. J. Exp. Med. 181:867-875.
33. Winchester, R., and E. Dwyer. 1991. MHC and autoimmune diseases: susceptibility to rheumatoid arthritis associated with a hydrophobic strip of alpha helix encoded by several MHC alleles. Immunol. Ser. 55:203-219.
34. Albani, S., D.A. Carson, and J. Roudier. 1992. Genetic and environmental factors in the immune pathogenesis of rheumatoid arthritis. Rheum. Dis. Clin. N. Am. 18:729-740.
35. Zanelli, E., C.J. Krco, J.M. Baisch, S. Cheng, and C.S. David. 1996. Immune response of HLA-DQ8 transgenic mice to peptides from the third hypervariable region of HLA-DRB1 correlates with predisposition to rheumatoid arthritis. Proc. Natl. Acad. Sci. USA. 93:1814-1819.
36. Nabozny, G.H., J.M. Baisch, S. Cheng, D. Cosgrove, M.M. Griffiths, H.S. Luthra, and C.S. David. 1996. HLA-DQ8 transgenic mice are highly susceptible to collagen-induced arthritis: a novel model for human polyarthritis. J. Exp. Med. 183:27-37.
37. Terato, K., H. Arai, Y. Shimozuru, T. Fukuda, H. Tanaka, H. Watanabe, Y. Nagai, K. Fujimoto, F. Okubo, F. Cho et al. 1989. Sex-linked differences in susceptibility of cynomolgus monkeys to type II collagen-induced arthritis: evidence that epitope-specific immune suppression is involved in the regulation of type II collagen autoantibody formation. Arthritis Rheum. 6:748-758.
38. Jasin, H.E. 1985. Autoantibody specificities of immune complexes sequestered in articular cartilage of patients with rheumatoid arthritis and osteoarthritis. Arthritis Rheum. 28:241-248.
39. Watson, W., M. Cremer, P. Wooley, and A. Townes. 1986. Assessment of the potential pathogenicity of type II collagen autoantibodies in patients with rheumatoid arthritis. Arthritis Rheum. 29:1316-1321.
40. Terato, K., Y. Shimozuru, K. Katayama, Y. Takemitsu, I. Yamashita, M. Miyatsu, K. Fujii, M. Sagara, S. Kobayashi, M. Goto et al. 1990. Specificity of antibodies to type II collagen in rheumatoid arthritis. Arthritis Rheum. 33:1493-1500.
41. Vignali, D.A., J. Moreno, D. Schiller, and G.J. Hammerling. 1992. Species-specific binding of CD4 to the beta 2 domain of major histocompatibility complex class II molecules. J. Exp. Med. 175:925-932.
42. Lamarre, D., A. Ashkenazi, S. Fleury, D.H. Smith, R.P. Sekaly, and D.J. Capon. 1989. The MHC-binding and gp120-binding functions of CD4 are separable. Science (Wash. DC). 245:743-746.
43. Rosloniec, E.F., K.B. Whittington, D.D. Brand, L.K. Myers, and J.M. Stuart. 1996. Identification of MHC class II and TCR binding residues in the type II collagen immunodominant determinant mediating collagen induced arthritis. Cell. Immunol. 172:21-28.
44. Fugger, L., J.B. Rothbard, and G. Sonderstrup-McDevitt. 1996. Specificity of an HLA-DRB 1*0401-restricted T cell response to type II collagen. Eur. J. Immunol. 26:928-933.